The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Open accessAbstract
Endothelium‐dependent contractions contribute to endothelial dysfunction in various animal models of aging, diabetes and cardiovascular diseases. In the spontaneously hypertensive rat, the archetypal model for endothelium‐dependent contractions, the production of the endothelium‐derived contractile factors (EDCF) involves an increase in endothelial intracellular calcium concentration, the production of reactive oxygen species, the predominant activation of cyclooxygenase‐1 (COX‐1) and to a lesser extent that of COX‐2, the diffusion of EDCF towards the smooth muscle cells and the subsequent stimulation of their thromboxane A2‐endoperoxide TP receptors. Endothelium‐dependent contractions are also observed in various models of hypertension, aging and diabetes. They generally also involve the generation of COX‐1‐ and/or COX‐2‐derived products and the activation of smooth muscle TP receptors. Depending on the model, thromboxane A 2, PGH 2, PGF 2α, PGE 2 and paradoxically PGI 2 can all act as EDCFs. In human, the production of COX‐derived EDCF is a characteristic of the aging and diseased blood vessels, with essential hypertension causing an earlier onset and an acceleration of this endothelial dysfunction. As it has been observed in animal models, COX‐1, COX‐2 or both isoforms can contribute to these endothelial dysfunctions. Since in most cases, the activation of TP receptors is the common downstream effector, selective antagonists of this receptor should curtail endothelial dysfunction and be of therapeutic interest in the treatment of cardiovascular disorders. LINKED ARTICLES This article is part of a themed issue on Vascular Endothelium in Health and Disease. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐3
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Reid, H. M., & Kinsella, B. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309314200 · Cited by 56
RetractedReid, H. M., & Kinsella, B. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a116.309314 · Cited by 55
RetractedFurchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada, S., & Vane, J. R. (1978) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06759-6 · Cited by 1,576
Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., & Dey, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80402-x · Cited by 1,430
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationRadomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,164
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Lüscher, T. F., & Vanhoutte, P. M. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.344 · Cited by 878
Self-citationHata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Self-citationRadomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11310.x · Cited by 816
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Aging and Endothelial Function in Normotensive Subjects and Patients With Essential Hypertension
Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Gennari, A., Fasolo, C. B., Sudano, I., & Salvetti, A. (1995) · Circulation · doi:10.1161/01.cir.91.7.1981 · Cited by 712
Zou, M., Shi, C., & Cohen, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14442 · Cited by 685
Moncada, S., Herman, A. G., Higgs, E. A., & Vane, J. R. (1977) · Thrombosis Research · doi:10.1016/0049-3848(77)90185-2 · Cited by 680
Prostaglandin endoperoxide synthase: structure and catalysis
Smith, W. L., & Marnett, L. J. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90119-3 · Cited by 601
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Vasodilation to acetylcholine in primary and secondary forms of human hypertension.
Taddei, S., Virdis, A., Mattei, P., & Salvetti, A. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.929 · Cited by 535
Zou, M.-H., Shi, C., & Cohen, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214442 · Cited by 494
Interactions of oxidants with vascular signaling systems
Wolin, M. S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1430 · Cited by 463
Distinct functions of COX-1 and COX-2
Morita, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00029-1 · Cited by 462
Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
Nakahata, N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.001 · Cited by 443
Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells
Law, R. E., Goetze, S., Xi, X.-P., Jackson, S., Kawano, Y., Demer, L., Fishbein, M. C., Meehan, W. P., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.11.1311 · Cited by 442
Burke, J. E., & Dennis, E. A. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6132-9 · Cited by 431
COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
Egan, K. M., Lawson, J. A., Fries, S., Koller, B., Rader, D. J., Smyth, E. M., & FitzGerald, G. A. (2004) · Science · doi:10.1126/science.1103333 · Cited by 431
Kobayashi, T., Tahara, Y., Matsumoto, M., Iguchi, M., Sano, H., Murayama, T., Arai, H., Oida, H., Yurugi-Kobayashi, T., Yamashita, J. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421446 · Cited by 373
Jackson, S. M., Parhami, F., Xi, X.-P., Berliner, J. A., Hsueh, W. A., Law, R. E., & Demer, L. L. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2094 · Cited by 373
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 358
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
Koller, A., Sun, D., & Kaley, G. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1276 · Cited by 329
Hypertension Causes Premature Aging of Endothelial Function in Humans
Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Fasolo, C. B., Sudano, I., & Salvetti, A. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.736 · Cited by 316
Hirata, T., Ushikubi, F., Kakizuka, A., Okuma, M., & Narumiya, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118518 · Cited by 301
Endothelium‐dependent contractions in hypertension
Vanhoutte, P. M., Feletou, M., & Taddei, S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706042 · Cited by 284
Self-citationCoagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.
Thomas, D. W., Mannon, R. B., Mannon, P. J., Latour, A., Oliver, J. A., Hoffman, M., Smithies, O., Koller, B. H., & Coffman, T. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5116 · Cited by 276
Clapp, L. H., Finney, P. A., Turcato, S., Tran, S., Rubin, L. J., & Tinker, A. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.2.4695 · Cited by 262
Zou, M.-H., Shi, C., & Cohen, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.1.198 · Cited by 261
Kato, T., Iwama, Y., Okumura, K., Hashimoto, H., Ito, T., & Satake, T. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.475 · Cited by 247
Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances
Legler, D. F., Bruckner, M., Uetz-von Allmen, E., & Krause, P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.09.015 · Cited by 233
Murakami, M., Nakatani, Y., Tanioka, T., & Kudo, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00043-6 · Cited by 232
Prostaglandin H Synthase and Vascular Function
Davidge, S. T. (2001) · Circulation Research · doi:10.1161/hh2001.098351 · Cited by 232
Gluais, P., Lonchampt, M., Morrow, J. D., Vanhoutte, P. M., & Feletou, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706390 · Cited by 230
Self-citationNational Cancer Institute (2020) · Definitions · doi:10.32388/aqq6w5 · Cited by 220
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Koga, T., Takata, Y., Kobayashi, K., Takishita, S., Yamashita, Y., & Fujishima, M. (1989) · Hypertension · doi:10.1161/01.hyp.14.5.542 · Cited by 218
Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions.
Auch-Schwelk, W., Katusic, Z. S., & Vanhoutte, P. M. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.699 · Cited by 207
Self-citationChataigneau, T., Félétou, M., Huang, P. L., Fishman, M. C., Duhault, J., & Vanhoutte, P. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702300 · Cited by 206
Self-citationCyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension
Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., & Salvetti, A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.274 · Cited by 206
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
Wang, M., Zukas, A. M., Hui, Y., Ricciotti, E., Puré, E., & FitzGerald, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606586103 · Cited by 205
Prostaglandin synthases: recent developments and a novel hypothesis
Helliwell, R. J. A., Adams, L. F., & Mitchell, M. D. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.002 · Cited by 203
Urade, Y., & Eguchi, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00042-4 · Cited by 203
Xiao, C.-Y., Hara, A., Yuhki, K.-I., Fujino, T., Ma, H., Okada, Y., Takahata, O., Yamada, T., Murata, T., Narumiya, S., et al. (2001) · Circulation · doi:10.1161/hc4301.098058 · Cited by 197
Auch-Schwelk, W., Katusic, Z. S., & Vanhoutte, P. M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.859 · Cited by 194
Self-citationThe isoprostanes in biology and medicine
Praticò, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00411-8 · Cited by 188
Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
Komers, R., Lindsley, J. N., Oyama, T. T., Schutzer, W. E., Reed, J. F., Mader, S. L., & Anderson, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10228 · Cited by 188
Sun, D., Huang, A., Smith, C. J., Stackpole, C. J., Connetta, J. A., Shesely, E. G., Koller, A., & Kaley, G. (1999) · Circulation Research · doi:10.1161/01.res.85.3.288 · Cited by 186
Function of prostanoid receptors: studies on knockout mice
Kobayashi, T., & Narumiya, S. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00055-2 · Cited by 185
Tang, E. H. C., & Vanhoutte, P. M. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00136.2007 · Cited by 182
Self-citationEndothelium-dependent contraction to stretch in canine basilar arteries
Katusic, Z. S., Shepherd, J. T., & Vanhoutte, P. M. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.252.3.h671 · Cited by 181
Self-citationTsuboi, K., Sugimoto, Y., & Ichikawa, A. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00054-0 · Cited by 180
Ge, T., Hughes, H., Junquero, D. C., Wu, K. K., Vanhoutte, P. M., & Boulanger, C. M. (1995) · Circulation Research · doi:10.1161/01.res.76.6.1003 · Cited by 180
Self-citationAndersohn, F., Suissa, S., & Garbe, E. (2006) · Circulation · doi:10.1161/circulationaha.105.602425 · Cited by 178
The enzymology of prostaglandin endoperoxide H synthases-1 and -2
Smith, W. L., & Song, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00025-4 · Cited by 173
Endothelium‐derived factors and hyperpolarization of the carotid artery of the guinea‐pig
Corriu, C., Félétou, M., Canet, E., & Vanhoutte, P. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15765.x · Cited by 172
Self-citationProstanoid receptor antagonists: development strategies and therapeutic applications
Jones, R., Giembycz, M. A., & Woodward, D. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00317.x · Cited by 172
Prostaglandin E Synthase, a Terminal Enzyme for Prostaglandin E2 Biosynthesis
Kudo, I., & Murakami, M. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.6.633 · Cited by 165
Kuwano, K., Hashino, A., Asaki, T., Hamamoto, T., Yamada, T., Okubo, K., & Kuwabara, K. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124248 · Cited by 164
Yang, D., Félétou, M., Boulanger, C. M., Wu, H., Levens, N., Zhang, J., & Vanhoutte, P. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704669 · Cited by 162
Self-citationEndothelium‐dependent contractions in SHR: a tale of prostanoid TP and IP receptors
Félétou, M., Verbeuren, T. J., & Vanhoutte, P. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00060.x · Cited by 162
Self-citationProstaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models
Hara, S., Kamei, D., Sasaki, Y., Tanemoto, A., Nakatani, Y., & Murakami, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.007 · Cited by 161
Prostaglandin E 2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP 4
Xiao, C.-Y., Yuhki, K.-I., Hara, A., Fujino, T., Kuriyama, S., Yamada, T., Takayama, K., Takahata, O., Karibe, H., Taniguchi, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128046.54681.97 · Cited by 160
Endothelium‐dependent hyperpolarizations: Past beliefs and present facts
Félétou, M., & Vanhoutte, P. M. (2007) · Annals of Medicine · doi:10.1080/07853890701491000 · Cited by 159
Self-citationBelhassen, L., Pelle, G., Dubois‐Randé, J., & Adnot, S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00048-2 · Cited by 154
Wong, S. L., Leung, F. P., Lau, C. W., Au, C. L., Yung, L., Yao, X., Chen, Z., Vanhoutte, P. M., Gollasch, M., & Huang, Y. (2008) · Circulation Research · doi:10.1161/circresaha.108.179770 · Cited by 154
Self-citationThromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia
Takayama, K., Yuhki, K., Ono, K., Fujino, T., Hara, A., Yamada, T., Kuriyama, S., Karibe, H., Okada, Y., Takahata, O., et al. (2005) · Nature Medicine · doi:10.1038/nm1231 · Cited by 152
Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase
Miller, V. M., & Vanhoutte, P. M. (1985) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1985.248.4.h432 · Cited by 151
Self-citationDeWitt, D. L., Day, J. S., Sonnenburg, W. K., & Smith, W. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111151 · Cited by 147
Role for Thromboxane Receptors in Angiotensin-II–Induced Hypertension
Francois, H., Athirakul, K., Mao, L., Rockman, H. A., & Coffman, T. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000112225.27560.24 · Cited by 144
Wang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2008) · Circulation · doi:10.1161/circulationaha.107.731398 · Cited by 142
Tang, E. H. C., Leung, F., Huang, Y., Félétou, M., So, K., Man, R. Y. K., & Vanhoutte, P. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707190 · Cited by 141
Self-citationWatanabe, K. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00044-8 · Cited by 138
Schmidt, P., Youhnovski, N., Daiber, A., Balan, A., Arsic, M., Bachschmid, M. M., Przybylski, M., & Ullrich, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208080200 · Cited by 138
Wong, W. T., Tian, X. Y., Chen, Y., Leung, F. P., Liu, L., Lee, H. K., Ng, C., Xu, A., Yao, X., Vanhoutte, P. M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.222794 · Cited by 137
Self-citationKatušić, Z. S., Shepherd, J. T., & Vanhoutte, P. M. (1988) · Stroke · doi:10.1161/01.str.19.4.476 · Cited by 136
Self-citationWong, G. L., Wong, V. W., Choi, P. C., Chan, A. W. H., & CHAN, H. L. Y. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04276.x · Cited by 135
Matsumoto, T., Noguchi, E., Ishida, K., Kobayashi, T., Yamada, N., & Kamata, K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00486.2008 · Cited by 132
Szerafin, T., Erdei, N., Fülöp, T., Pásztor, E. T., Edes, I. F., Koller, Á., & Bagi, Z. A. (2006) · Circulation Research · doi:10.1161/01.res.0000241051.83067.62 · Cited by 131
Blanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126
Arehart, E. J., Stitham, J., Asselbergs, F. W., Douville, K. L., MacKenzie, T. A., Fetalvero, K. M., Gleim, S., Kasza, Z., Rao, Y., Martel, L., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.165936 · Cited by 124
Taba, Y., Sasaguri, T., Miyagi, M., Abumiya, T., Miwa, Y., Ikeda, T., & Mitsumata, M. (2000) · Circulation Research · doi:10.1161/01.res.86.9.967 · Cited by 123
Molecular cloning of human platelet thromboxane a synthase
Yokoyama, C., Miyata, A., Ihara, H., Ullrich, V., & Tanabe, T. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91060-p · Cited by 123
Prostaglandin F 2α elevates blood pressure and promotes atherosclerosis
Yu, Y., Lucitt, M. B., Stubbe, J., Cheng, Y., Friis, U. G., Hansen, P., Jensen, B. L., Smyth, E. M., & FitzGerald, G. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811834106 · Cited by 120
COX-mediated endothelium-dependent contractions: from the past to recent discoveries
Wong, M. S. K., & Vanhoutte, P. M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.127 · Cited by 118
Self-citationA Diffusible Substance(s) Mediates Endothelium-Dependent Contractions in the Aorta of SHR
Yang, D., Félétou, M., Levens, N. R., Zhang, J. N., & Vanhoutte, P. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000047651.45322.16 · Cited by 117
Self-citationCardioprotective prostacyclin signaling in vascular smooth muscle
Fetalvero, K. M., Martin, K. A., & Hwa, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.011 · Cited by 116
Cellular and molecular biology of prostacyclin synthase
Wu, K. K., & Liou, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.021 · Cited by 116
Identification of specific EP receptors responsible for the hemodynamic effects of PGE2
Audoly, L., Tilley, S. L., Goulet, J. L., Key, M. L., Nguyen, M., Stock, J. L., McNeish, J. D., Koller, B. H., & Coffman, T. M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h924 · Cited by 116
Hristovska, A.-M., Rasmussen, L. E., Hansen, P., Nielsen, S. S., Nüsing, R. M., Narumiya, S., Vanhoutte, P. M., Skøtt, O., & Jensen, B. L. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088948 · Cited by 116
Self-citationRapoport, R. M., & Williams, S. P. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.64 · Cited by 114
Loftin, C. D., Tiano, H. F., & Langenbach, R. J. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00028-x · Cited by 114
The Diabetic Kidney: From Hyperfiltration and Microalbuminuria to End-stage Renal Failure
Mogensen, C. E., & Schrnitz, O. (1988) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30717-9 · Cited by 110
Ma, H., Hara, A., Xiao, C. Y., Okada, Y., Takahata, O., Nakaya, K., Sugimoto, Y., Ichikawa, A., Narumiya, S., & Ushikubi, F. (2001) · Circulation · doi:10.1161/hc3601.094003 · Cited by 110
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
Guan, Y., Zhang, Y., Wu, J., Qi, Z., Yang, G., Dou, D., Gao, Y., Chen, L., Zhang, X., Davis, L. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29838 · Cited by 109
Prostacyclin and endothelium-dependent hyperpolarization
Parkington, H. C. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.012 · Cited by 108
Wilson, S. J., Roche, A. M., Kostetskaia, E., & Smyth, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405002200 · Cited by 108
Matsumoto, T., Kakami, M., Noguchi, E., Kobayashi, T., & Kamata, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00229.2007 · Cited by 105
Balancing prostanoid activity in the human vascular system
Flavahan, N. A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.01.003 · Cited by 104
Schweda, F., Klar, J., Narumiya, S., Nüsing, R. M., & Kurtz, A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2004 · Cited by 104
Cyclo‐oxygenase‐1 and −2 contribution to endothelial dysfunction in ageing
Heymes, C., Habib, A., Yang, D., Mathieu, E., Marotte, F., Samuel, J., & Boulanger, C. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703632 · Cited by 103
Tang, E. H. C., Ku, D. D., Tipoe, G. L., Félétou, M., Man, R. Y. K., & Vanhoutte, P. M. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000187174.67661.67 · Cited by 103
Self-citationDegousée, N., Fazel, S. S., Angoulvant, D., Stefanski, E., Pawelzik, S., Korotkova, M., Arab, S., Liu, P. J., Lindsay, T. F., Sun, Z., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.749739 · Cited by 102
Wang, B., Pan, J., Wang, L., Zhu, H., Yu, R., & Zou, Y. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.008 · Cited by 102
García-Cohen, E. C., Marín, J., Díez-Picazo, L. D., Baena, A. B., Salaíces, M., & Rodríguez-Martínez, M. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39205-5 · Cited by 101
Behm, D. J., Ogbonna, A. C., Wu, C. W., Burns-Kurtis, C. L., & Douglas, S. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145102 · Cited by 101
Matsumoto, T., Nakayama, N., Ishida, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.148718 · Cited by 100
Jia, Z., Zhang, A., Zhang, H., Dong, Z., & Yang, T. (2006) · Circulation Research · doi:10.1161/01.res.0000251306.40546.08 · Cited by 96
Wong, M. S. K., Delansorne, R., Man, R. Y. K., Svenningsen, P., & Vanhoutte, P. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00288.2010 · Cited by 95
Self-citationÁlvarez, Y., Briones, A. M., Balfagón, G., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163145.12707.63 · Cited by 91
Orai, STIM1 and iPLA2β: a view from a different perspective
Bolotina, V. M. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.154997 · Cited by 87
Shi, Y., Félétou, M., Ku, D. D., Man, R. Y. K., & Vanhoutte, P. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706999 · Cited by 84
Self-citationMitchell, J. A., Lucas-Domínguez, R., Vojnovic, I., Hasan, K., Pepper, J., & Warner, T. D. (2006) · The FASEB Journal · doi:10.1096/fj.06-6615com · Cited by 82
Nacci, C., Tarquinio, M., Benedictis, L. D., Mauro, A., Zigrino, A., Carratù, M. R., Quon, M. J., & Montagnani, M. (2008) · Endocrinology · doi:10.1210/en.2008-1069 · Cited by 80
The Thromboxane/Endoperoxide Receptor (TP): The Common Villain
Félétou, M., Vanhoutte, P. M., & Verbeuren, T. J. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d8bc8a · Cited by 79
Self-citationNumaguchi, Y., Harada, M., Osanai, H., Hayashi, K., Toki, Y., Okumura, K., Ito, T., & Hayakawa, T. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00239-9 · Cited by 79
Boffa, J., Just, A., Coffman, T. M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000136300.72480.86 · Cited by 78
Gluais, P., Paysant, J., Badier‐Commander, C., Verbeuren, T. J., Vanhoutte, P. M., & Félétou, M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01115.2005 · Cited by 77
Self-citationVerma, S., Raj, S. R., Shewchuk, L., Mather, K. J., & Anderson, T. J. (2001) · Circulation · doi:10.1161/hc4901.101350 · Cited by 77
Xavier, F. E., Aras‐López, R., Arroyo-Villa, I., del Campo, L., Salaíces, M., Rossoni, L. V., Ferrer, M., & Balfagón, G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.200 · Cited by 73
Bulut, D., Liaghat, S., Hanefeld, C., Koll, R., Miebach, T., & gge, A. M. U. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00015 · Cited by 70
Duffy, S. J., Tran, B. T., New, G., Tudball, R., Esler, M., Harper, R. W., & Meredith, I. T. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.4.h1174 · Cited by 69
Shi, Y., Man, R. Y., & Vanhoutte, P. M. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00749.x · Cited by 69
Self-citationTang, E. H. C., Jensen, B. L., Skøtt, O., Leung, G., Félétou, M., Man, R. Y. K., & Vanhoutte, P. M. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm112 · Cited by 67
Self-citationVirdis, A., Colucci, R., Versari, D., Ghisu, N., Fornai, M., Antonioli, L., Duranti, E., Daghini, E., Giannarelli, C., Blandizzi, C., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132258 · Cited by 67
Yang, D., Gluais, P., Zhang, J. N., Vanhoutte, P. M., & Félétou, M. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00247.x · Cited by 65
Self-citationMultiple signalling options for prostacyclin.
Wise, H. M. (2003) · PubMed · Cited by 59
Smyth, E. M., & FitzGerald, G. A. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65063-0 · Cited by 58
Role of Microsomal Prostaglandin E Synthase 1 in the Kidney
Francois, H., Facemire, C. S., Kumar, A., Audoly, L., Koller, B. H., & Coffman, T. M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040343 · Cited by 58
García‐Redondo, A. B., Briones, A. M., Beltrán, A. E., Alonso, M. J., Simonsen, U., & Salaíces, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144295 · Cited by 57
Yu, I.-S. (2004) · Blood · doi:10.1182/blood-2003-10-3661 · Cited by 55
Wilson, S. J., Cavanagh, C. C., Lesher, A. M., Frey, A. J., Russell, S. E., & Smyth, E. M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800447-jlr200 · Cited by 54
Orie, N. N., Fry, C. H., & Clapp, L. H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.004 · Cited by 53
Wilson, S. J., Dowling, J. K., Zhao, L., Carnish, E. R., & Smyth, E. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000252667.53790.4e · Cited by 53
Zygmunt, P. M., Plane, F., Paulsson, M. A., Garland, C. J., & Högestätt, E. D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701893 · Cited by 52
Synthesis of 8-epi-prostaglandin F2α by human endothelial cells: role of prostaglandin H2 synthase
Watkins, M. T., Patton, G. M., Soler, H. M., Albadawi, H., Humphries, D. E., EVANS, J. E., & KADOWAKI, H. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440747 · Cited by 51
McClelland, S., Gawaz, M., Kennerknecht, E., Konrad, C. S. I., Sauer, S., Schürzinger, K., Maßberg, S., Fitzgerald, D. J., & Belton, O. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.016 · Cited by 50
The Mechanism of Oxidative Stress Stabilization of the Thromboxane Receptor in COS-7 Cells
Valentin, F., Field, M. C., & Tippins, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306761200 · Cited by 50
Yang, D., Gluais, P., Zhang, J. N., Vanhoutte, P. M., & Félétou, M. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200406000-00011 · Cited by 48
Self-citationAdeagbo, A. S. O., Zhang, X., Patel, D., Joshua, I. G., Wang, Y., Sun, X., Igbo, I. N., & Oriowo, M. A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166844.42227.5c · Cited by 48
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2
Warner, T. D., Vojnovic, I., Bishop‐Bailey, D., & Mitchell, J. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-4434fje · Cited by 47
Simonet, S., Descombes, J., Vallez, M., Dubuffet, T., Lavielle, G., & Verbeuren, T. J. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1810-9_35 · Cited by 46
Specific Potentiation of Endothelium-Dependent Contractions in SHR by Tetrahydrobiopterin
Yang, D., Levens, N. R., Zhang, J. N., Vanhoutte, P. M., & Félétou, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000047669.93078.a7 · Cited by 46
Self-citationLiu, C., Leung, F. P., Wong, S. L., Wong, W. T., Lau, C. W., Lü, L., Yao, X., Yao, T., & Huang, Y. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.022 · Cited by 46
Self-citationAging and prostacyclin responses in aorta and platelets from WKY and SHR rats
Gomez, É., Schwendemann, C., Roger, S., Simonet, S., Paysant, J., Vayssettes‐Courchay, C., Verbeuren, T. J., & Félétou, M. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00507.2008 · Cited by 45
Self-citationMechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aorta
Gluais, P., Vanhoutte, P. M., & Félétou, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.050 · Cited by 43
Self-citationDelannoy, E., Courtois, A., Freund‐Michel, V., Leblais, V., Marthan, R., & Müller, B. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp292 · Cited by 43
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk
Rovati, G. E., Sala, A., Capra, V., Dahlén, S., & Folco, G. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.007 · Cited by 42
Wade, M. L., & Fitzpatrick, F. A. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0348 · Cited by 41
Okon, E. B., Golbabaie, A., & van Breemen, C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704884 · Cited by 41
Wong, M. S. K., Man, R. Y. K., & Vanhoutte, P. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01068.2009 · Cited by 41
Self-citationKawka, D. W., Ouellet, M., Hétu, P., Singer, I. I., & Riendeau, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.015 · Cited by 40
Bolla, M., You, D., Loufrani, L., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000127438.39744.07 · Cited by 38
Meeking, D. R., Browne, D. L., Allard, S., Munday, J., Chowienczyck, P. J., Shaw, K. M., & Cummings, M. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1840 · Cited by 38
Kamgar, M., Nobakhthaghighi, N., Shamshirsaz, A. A., Estacio, R. O., McFann, K., & Schrier, R. W. (2006) · Kidney International · doi:10.1038/sj.ki.5000355 · Cited by 35
Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries
de Sotomayor, M. Á., Mingorance, C., & Andriantsitohaina, R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.041 · Cited by 35
Qu, C., Leung, S. W. S., Vanhoutte, P. M., & Man, R. Y. K. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167098 · Cited by 35
Self-citationTP Receptors and Oxidative Stress
Félétou, M., Cohen, R. A., Vanhoutte, P. M., & Verbeuren, T. J. (2010) · Advances in pharmacology · doi:10.1016/b978-0-12-385061-4.00004-0 · Cited by 34
Self-citationAre endothelium-derived hyperpolarizing and contracting factors isoprostanes?
Janssen, L. J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01890-4 · Cited by 32
Stitham, J., Gleim, S., Douville, K. L., Arehart, E. J., & Hwa, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604042200 · Cited by 30
Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig
Corriu, C., Félétou, M., Edwards, G., Weston, A. H., & Vanhoutte, P. M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01203-1 · Cited by 28
Self-citationThromboxane A2inhibition of SKCaafter NO synthase block in rat middle cerebral artery
McNeish, A. J., & Garland, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707240 · Cited by 26
Matsumoto, T., Takaoka, E., Ishida, K., Nakayama, N., Noguchi, E., Kobayashi, T., & Kamata, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.015 · Cited by 24
A novel genetic model of selective COX-2 inhibition: Comparison with COX-2 null mice
Yu, Y., & Funk, C. D. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.021 · Cited by 23
Matsumoto, T., Ishida, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09116fp · Cited by 22
BLANCORIVERO, J., MARQUEZRODAS, I., XAVIER, F., ARASLOPEZ, R., ARROYOVILLA, I., FERRER, M., & BALFAGON, G. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.006 · Cited by 21
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Self-citationMacro‐ and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Shi, Y., & Vanhoutte, P. M. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12521 · Cited by 545
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Vanhoutte, P. M., Zhao, Y., Xu, A., & Leung, S. W. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.306531 · Cited by 392
Self-citationOverview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
Ghoshal, K., & Bhattacharyya, M. (2014) · The Scientific World Journal · doi:10.1155/2014/781857 · Cited by 347
Metadata
- Authors
- Félétou, M., Huang, Y., & Vanhoutte, P. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-09-08
- Volume
- 164
- Issue
- 3
- Pages
- 894-912
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1844380018
- Cited by
- 372
- References
- 185
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.